Abstract

Apolipoprotein A-I (apo A-I), the major protein component of high-density lipoprotein, has been proven inversely correlated to cardiovascular risk in past decades. The lipid-free state of apo A-I is the initial stage which binds to lipids forming high-density lipoprotein. Molecular models of lipid-free apo A-I have been reported by methods like X-ray crystallography and chemical cross-linking/mass spectrometry (CCL/MS). Through structural analysis we found that those current models had limited consistency with other experimental results, such as those from hydrogen exchange with mass spectrometry. Through molecular dynamics simulations, we also found those models could not reach a stable equilibrium state. Therefore, by integrating various experimental results, we proposed a new structural model for lipid-free apo A-I, which contains a bundled four-helix N-terminal domain (1–192) that forms a variable hydrophobic groove and a mobile short hairpin C-terminal domain (193–243). This model exhibits an equilibrium state through molecular dynamics simulation and is consistent with most of the experimental results known from CCL/MS on lysine pairs, fluorescence resonance energy transfer and hydrogen exchange. This solution-state lipid-free apo A-I model may elucidate the possible conformational transitions of apo A-I binding with lipids in high-density lipoprotein formation.

Highlights

  • High-density lipoprotein (HDL) has been intensively studied for decades due to its inverse correlation with the risk of cardiovascular diseases (CVDs) [1]

  • The protein component of HDL is apolipoprotein A-I, a 28-kDa 243 residue polypeptide synthesized by the liver and small intestine, which assembles into HDL particles and modulates reverse cholesterol transport (RCT) [2]

  • By using MD simulations along with previous experimental results, we proposed a full length all-atom Apolipoprotein A-I (apo A-I) model, molecular dynamics (MD) model, and detailed analysis compared to known experimental results

Read more

Summary

Introduction

High-density lipoprotein (HDL) has been intensively studied for decades due to its inverse correlation with the risk of cardiovascular diseases (CVDs) [1]. Through reverse cholesterol transport (RCT), HDL promotes cholesterol efflux from tissues to the liver for degradation. The protein component of HDL is apolipoprotein A-I (apoA-I), a 28-kDa 243 residue polypeptide synthesized by the liver and small intestine, which assembles into HDL particles and modulates RCT [2]. Apo A-I is found in both the lipid-free and lipid-bound states [3]. The major function of lipid-free apo A-I is to gather efflux cholesterol and other lipid.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call